Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-05-17FDA Approved: TELMISARTAN — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for telmisartan filed by Mylan Pharmaceuticals Inc., granting approval for the generic telmisart…
-
CLINICAL_TRIALS trial_result · 2019-05-13Clinical Trial Update: Registry to Evaluate the ROX COUPLER in Patients With Resistant or Uncontrolled Hypertension [Phase 3]
Phase 3 clinical trial registry update for ROX COUPLER in patients with resistant or uncontrolled hypertension has completed.
-
FDA approval · 2019-05-13FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (Cadila Pharmaceuticals Limited)
FDA approved labetalol hydrochloride as a generic drug under an original application from Cadila Pharmaceuticals Limited.
-
FDA approval · 2019-05-10FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the generic amlodipine besylate and atorvastatin calcium combination (amlodipine and atorvastati…
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: A Multicenter Study to Evaluate the ROX Arteriovenous Coupler in Patients With Treatment-Resistant Hypertension [Phase 3]
A Phase 3 multicenter trial evaluating the ROX Arteriovenous Coupler for treatment-resistant hypertension has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-05-10FDA Approved: CHLORTHALIDONE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for chlorthalidone from Zydus Lifesciences Limited, granting generic approval under ANDA207813.
-
CLINICAL_TRIALS trial_result · 2019-05-09Clinical Trial Update: Pilot Study of an Intervention Involving Cognitive Training and tDCS in Morbidly Obese Subjects [Phase 2]
Phase 2 pilot study evaluating the effects of cognitive training combined with transcranial direct current stimulation (tDCS) in morbidly ob…
-
FDA approval · 2019-05-07FDA Approved: TELMISARTAN AND AMLODIPINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA-approved Lupin Pharmaceuticals' supplemental application for a Telmisartan and Amlodipine fixed-dose combination, enabling the generic p…
-
FDA approval · 2019-05-07FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Telmisartan and Hydrochlorothiazide, a generic combination used to treat hy…
-
FDA approval · 2019-05-07FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Losartan Potassium from Unichem Pharmaceuticals (USA), Inc., authorizing the marketing of a gene…
-
FDA approval · 2019-05-07FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Micro Labs Limited)
Supplemental application for Losartan Potassium from Micro Labs Limited has been approved by the FDA.
-
FDA approval · 2019-05-03FDA Approved: METOPROLOL TARTRATE — Supplemental Application (TRUPHARMA LLC)
FDA approved a supplemental application for metoprolol tartrate submitted by TRUPHARMA LLC.
-
FDA approval · 2019-05-03FDA Approved: FUROSEMIDE — Original Application (Eugia US LLC)
FDA approved an original ANDA for FUROSEMIDE by Eugia US LLC, confirming a generic version of the diuretic. This is a routine generic drug a…
-
FDA approval · 2019-04-29FDA Approved: FELODIPINE — Original Application (Carlsbad Technology, Inc.)
FDA approved Felodipine through an original application filed by Carlsbad Technology, Inc., for treatment of hypertension. Felodipine is als…
-
FDA approval · 2019-04-25FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for IRBESARTAN AND HYDROCHLOROTHIAZIDE, a generic fixed‑dose combination by Alembic Pharmaceuticals …
-
CLINICAL_TRIALS trial_result · 2019-04-24Clinical Trial Update: Pilot Study of of Renal Arterial Sympathetic Denervation by Cryotherapy [Phase 4]
Pilot Phase 4 study investigating renal arterial sympathetic denervation by cryotherapy for hypertension.
-
FDA approval · 2019-04-23FDA Approved: TELMISARTAN — Supplemental Application (Chartwell RX, LLC.)
The FDA approved a supplemental application to authorize a generic telmisartan product from Chartwell RX, LLC. Telmisartan is used to treat …
-
FDA approval · 2019-04-23FDA Approved: IRBESARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for Irbesartan (ANDA).
-
FDA approval · 2019-04-23FDA Approved: IRBESARTAN — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for IRBESARTAN from Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2019-04-22Clinical Trial Update: Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women. [Phase 4]
Phase 4 trial evaluating whether estrogen-progestin therapy reverses an unfavorable effect of hydrochlorothiazide on serum uric acid and oxy…
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis Patients [Phase 4]
Phase 4 trial assessing the effect of arotinolol hydrochloride on cardiovascular events in hypertensive patients undergoing haemodialysis.
-
FDA approval · 2019-04-16FDA Approved: TELMISARTAN — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for telmisartan from Alembic Pharmaceuticals Limited, indicating regulatory approval of changes to t…
-
FDA approval · 2019-04-16FDA Approved: TELMISARTAN — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Telmisartan submitted by Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Oral Nitrite in Adults With Metabolic Syndrome and Hypertension [Phase 2]
Phase 2 clinical trial update evaluating oral nitrite in adults with metabolic syndrome and hypertension; trial completed with results poste…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Blood Pressure Control in Acute Ischemic Stroke [Phase 2, Phase 3]
A Phase 2/Phase 3 trial update on blood pressure control in acute ischemic stroke has completed recruitment and status is completed.